The Times Online reports that researchers from the Institute of Ophthalmology at University College London and Moorfields eye hospital have developed stem cell therapy that can treat age-related macular degeneration (AMD), the most common cause of blindness
. They are currently moving the treatment through the regulatory approval process, and clinical trials are expected to start within two years. Quoting:
"Under the new treatment, embryonic stem cells are transformed into replicas of the missing cells. They are then placed on an artificial membrane which is inserted in the back of the retina. ... [Professor Pete Coffey, director of the London Project to Cure Blindness] said the treatment would take 'less than an hour, so it really could be considered as an outpatient procedure. We are trying to get it out as a common therapy.'